Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2023–2026 · research · R01
Multi-site feasibility and acceptability of a faith-based mind-body intervention in Black adults
Scherezade Kelly Mama · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Mechanisms of action and therapeutic targeting of the CARM1-NFIB axis in small cell lung cancer
Mark T. Bedford · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
The role of membrane homoeostasis of neural stem cell and glioma stem cells in neural development and gliomagenesis
Jian Hu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Optimizing treatment decision by accounting for longitudinal biomarker trajectories and competing risks of each individual
Xuelin Huang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Development of miR-27a* for the Treatment of Head and Neck Squamous Cell Carcinoma
Stephen Y Lai · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Dissecting and targeting mechanisms of genomic instability-triggered immune evasion in RBM10-deficient non-small cell lung cancer
Ferdinandos Skoulidis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · program · P50
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer
Di Zhao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
Albert Koong · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R37
Targeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBM
Sangeeta Goswami · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Targeting the LIFR-LCN2 pathway to improve liver cancer therapy
Li Ma · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2025 · research · R21
Preclinical studies of non-nucleoside DNMT3A/3B inhibitors
Taiping Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Shared Resources Core
Cesaltina Ferreira Lorenzoni · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Research Project #1
Shreela V Sharma · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · program · P50
Administrative Core
Anil K Sood · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · program · P50
Targeting EGFL6 in Ovarian Cancer
Anil K Sood · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Developmental Core
Qian Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Administrative Core
Karen M Basen-Engquist · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Admin Core
Kathleen Schmeler · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · program · P50
Targeting p300 to Overcome PARP inhibitor resistance induced by acidic tumor microenvironment
Rugang Zhang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Project 1
Regis Kreitchmann · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · program · P50
The SIK2 Inhibitor GRN-300 Enhances PARP Inhibitor Sensitivity and Cytotoxic T-Cell Function in Ovarian Cancer
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · program · P50
Developmental Research Program
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2025 · research · R01
Improving emergency care and outcomes of immune-related adverse events: The immune-related emergency disposition index (IrEDi)
Cielito C Reyes-Gibby · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development
Humam Kadara · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
Catherine L Elsinger · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2024 · research · R21
Integrating in vivo and in silico models of prostate cancer-bone interactions to overcome anti-tumor therapy resistance
Stefano Casarin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Acquired Resistance to Therapy and Iron (ARTI) Center
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Promoting remyelination in multiple sclerosis by simultaneously modulating myelin debris clearance and myelin lipid synthesis
Jian Hu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022 · grant · Academic Research
Fasting-induced microbiome changes and radioprotection
Helen Piwnica-Worms · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2022–2027 · research · R01
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
Chun Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2025 · research · R21
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults with Cancer: A two arm pilot study
Salahadin Abdi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Tumor cell lineage diversity and composition in gastric cancer progression and therapy resistance
Pawel K. Mazur · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022 · grant · Academic Research
Reversing Aging Associated Resistance to Cancer Immunotherapy
Wen Jiang · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2022 · grant · Academic Research
IRE-based Rational Combination for Effective PDAC Immunotherapy
Chun Li · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2022 · grant · Academic Research
Mechanisms and therapies focused on epigenomic alterations in therapy-resistant prostate cancers
Kunal Rai · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2022–2027 · cooperative agreement · U54
The Houston Center for Acquired Resistance Research (H-CARR)
Jeffrey Nicholas Myers · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2028 · research · R01
Establishing the clinical utility of a consensus DSC-MRI Protocol
Jerrold L Boxerman · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
BAF complex deregulation in lymphoma
Michael Richard Green · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2024 · research · R21
Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma Patients
Kathrin Milbury · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
